Characterizing the Use of Botulinum Toxin in Patients with Hirschsprung Disease Treated at Referral Institutions for Pediatric Colorectal Surgery
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Feb 2022 · 1 min read
In brief
In brief
Multicenter retrospective study examining botulinum toxin use patterns in pediatric Hirschsprung disease patients with obstructive symptoms across specialized colorectal surgery centers. Data from the Pediatric Colorectal and Pelvic Learning Consortium (2017-2021) characterizes treatment approaches at referral institutions.
Written by the GCMD Library team from the article.
Purpose
: Botulinum toxin (BT) is used to treat pediatric patients with Hirschsprung disease (HD) with obstructive symptoms. We aimed to characterize use of BT in HD patients across pediatric colorectal surgery referral centers.
Methods
: A multicenter retrospective study of BT use in children (0-18y) with HD was performed using the Pediatric Colorectal and Pelvic Learning Consortium (PCPLC) between 2017-2021. Sites with